Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dror Marchaim

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Infection Control and Hospital Epidemiology|March 8, 2014
Statewide surveillance of carbapenem-resistant enterobacteriaceae in MichiganBrenda M Brennan, Joseph R Coyle, Dror Marchaim, et al.
American Journal of Infection Control|July 18, 2016
Predictors of Clostridium difficile infection-related mortality among older adultsTeena Chopra, Reda A Awali, Caitlin Biedron, et al.
Infection Control and Hospital Epidemiology|August 11, 2011
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureusKayoko Hayakawa, Dror Marchaim, Celine Vidaillac, et al.
American Journal of Infection Control|March 24, 2012
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infectionsKimberly Ku, Jason M Pogue, Judy Moshos, et al.
Open Forum Infectious Diseases|February 18, 2016
Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258Sorabh Dhar, Emily T Martin, Paul R Lephart, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
Infection Control and Hospital Epidemiology|September 25, 2015
The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive AnalysisTsilia Lazarovitch, Keren Amity, Joseph R Coyle, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococciKayoko Hayakawa, Emily T Martin, Uma Mahesh Gudur, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Infection Control and Hospital Epidemiology|March 8, 2014
Statewide surveillance of carbapenem-resistant enterobacteriaceae in MichiganBrenda M Brennan, Joseph R Coyle, Dror Marchaim, et al.
American Journal of Infection Control|July 18, 2016
Predictors of Clostridium difficile infection-related mortality among older adultsTeena Chopra, Reda A Awali, Caitlin Biedron, et al.
Infection Control and Hospital Epidemiology|August 11, 2011
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureusKayoko Hayakawa, Dror Marchaim, Celine Vidaillac, et al.
American Journal of Infection Control|March 24, 2012
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infectionsKimberly Ku, Jason M Pogue, Judy Moshos, et al.
Open Forum Infectious Diseases|February 18, 2016
Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258Sorabh Dhar, Emily T Martin, Paul R Lephart, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
Infection Control and Hospital Epidemiology|September 25, 2015
The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive AnalysisTsilia Lazarovitch, Keren Amity, Joseph R Coyle, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococciKayoko Hayakawa, Emily T Martin, Uma Mahesh Gudur, et al.
The Annals of Pharmacotherapy|December 6, 2012
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agentsMichelle L Campbell, Dror Marchaim, Jason M Pogue, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coliTeena Chopra, Dror Marchaim, Jennifer Veltman, et al.
Pageof 11